Owens & Minor (NYSE:OMI) said this month that it named former Thermo Fisher Scientific chief commercial officer Edward Pesicka as its new prez & CEO, effective March 4. Pesicka will replace interim prez & CEO Robert Sledd, who will continue to serve as board chair, the Richmond, Va.-based company said. Prior to his position as chief […]
Deerfield-backed blank-check firm’s IPO raises $250m for healthcare plays
DFB Healthcare Acquisitions (NSDQ:DFBHU) said today that it closed a $250 million initial public offering. The firm’s IPO included 25,000,000 units priced at $10.00 apiece. Each unit consisted of one share of common stock and one-third of one warrant. The company said it expects its common stock to be listed on the Nasdaq under the […]
Court approves Nuo Therapeutics bankruptcy plan
Wound care company Nuo Therapeutics (OTC:NUOT) said yesterday that a federal court in Delaware approved a bankruptcy plan that would either see it continue as an independent company or become 95% owned by lender Deerfield Management. Gaithersburg, Md.-based Nuo filed for Chapter 11 bankruptcy protection in January, 2 years after raising $35 million from Deerfield. Formerly known as Cytomedix, […]
Nuo Therapeutics files for bankruptcy
Wound care company Nuo Therapeutics (OTC:NUOT) said yesterday that it’s declaring Chapter 11 bankruptcy a little more than 2 years after raising $35 million. Formerly known as Cytomedix, Nuo Therapeutics makes the Aurix hematogel, which is designed to stimulate the body’s native mechanisms to heal wounds. In April 2014, the company landed a $35 million investment from Deerfield […]
Diabetes: Fractyl Labs closes $57m Series C round
Fractyl Laboratories said today that it closed a Series C round worth $57 million with a final, $17 million tranche joined by new backer Deerfield Management, as it readies its Retiva device for a Phase II trial. Waltham, Mass.-based Fractyl calls the Retiva a “duodenal mucosal resurfacing” device; it’s designed to separate the mucosa and sub-mucosa […]
Ex-Siemens Healthcare exec Sorensen gets in on Deerfield’s Imris buy
Dr. Gregory Sorensen, the former chief of Siemens Healthcare (NYSE:SI) North America division, is taking out a minority stake in Deerfield Imaging, the former Imris business the investment company bought out of bankruptcy this year. Imris and 2 subsidiaries, including its NeuroArm Surgical business, filed for Chapter 11 bankruptcy protection last May, under a bailout plan with Deerfield Management. […]
Deerfield launches $550m healthcare fund
Deerfield Management said last week it launched a $550 million investment fund focused on the healthcare industry. The Deerfield Healthcare Innovations Fund, as it’s been titled, will seek to invest in companies looking to advance therapeutic interventions for genetic diseases, cancers and orphan diseases, as well as new disruptive technologies in the medical therapeutic delivery […]
Imris files for Chapter 11 bankruptcy
Imris Inc. (TSX:IM) said today that it and 2 subsidiaries, including its NeuroArm Surgical business, filed for Chapter 11 bankruptcy protection.
Tandem Diabetes plans $60m offering | Medtech funding for the week of March 2, 2015
EndoChoice raises $57m for Fuse endoscope
EndoChoice today said it raised $57 million for its Fuse full-spectrum endoscope from a group that included prior backers and new investors.
MassDevice Network
@MassDevice
LinkedIn
YouTube